← Back to Search

E-Cigarettes for Smoking in Substance Use Disorders

Phase 2
Led By Scott Sherman, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights

Study Summary

This trial will test whether e-cigarettes can help patients in addiction treatment quit smoking cigarettes, as they have higher rates of smoking than the general population.

Who is the study for?
This trial is for individuals who smoke at least 10 cigarettes daily, are in addiction treatment, and have had alcohol or opioid use disorder in the past year. Participants must be able to consent, interested in reducing smoking, use a cellphone for daily texts about their smoking and e-cigarette use but not currently using other tobacco products or cessation aids.Check my eligibility
What is being tested?
The study explores if e-cigarettes can help people with substance use disorders reduce harm from smoking. It involves giving participants either real or placebo e-cigarettes and monitoring their cigarette consumption over three weeks to see if there's any change.See study design
What are the potential side effects?
Potential side effects of nicotine replacement therapy like e-cigarettes may include throat irritation, coughing, headache, nausea, and dependency on the product. The exact side effects will depend on individual reactions to using e-cigarettes.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants who achieve 50% reduction in CPD at 3 weeks.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: E cigarettesExperimental Treatment1 Intervention
Group II: Nicotine Replacement TherapyActive Control1 Intervention

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,486 Total Patients Enrolled
Scott Sherman, MDPrincipal InvestigatorNYU Langone Health
4 Previous Clinical Trials
1,089 Total Patients Enrolled

Media Library

E-cigarettes Clinical Trial Eligibility Overview. Trial Name: NCT04063267 — Phase 2
Smoking/Cigarette Smoking Research Study Groups: E cigarettes, Nicotine Replacement Therapy
Smoking/Cigarette Smoking Clinical Trial 2023: E-cigarettes Highlights & Side Effects. Trial Name: NCT04063267 — Phase 2
E-cigarettes 2023 Treatment Timeline for Medical Study. Trial Name: NCT04063267 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are enrolled in this biomedical experiment?

"Affirmative, the clinicaltrials.gov page indicates that this trial is actively seeking recruits. The initial posting date of October 27th 2020 has been recently updated on August 8th 2022 - for a total of 240 participants to be enrolled from one location."

Answered by AI

Are there any geriatric patients participating in this experiment?

"As per the study's requirements, eligible participants must be between 18 and 65 years old."

Answered by AI

Are there still openings for potential participants of this research?

"Indeed, the information on clinicaltrials.gov verifies that this trial is still actively recruiting candidates. Initially posted on October 27th 2020, and most recently modified on August 8th 2022; 240 participants are required from a single medical centre."

Answered by AI

To what degree can using E-cigarettes be hazardous to one's health?

"There is some evidence that suggests e-cigarette use may be safe, giving it a score of 2 on our scale. Nonetheless, no clinical studies have yet been conducted to evaluate their efficacy in the treatment of any condition."

Answered by AI

To whom is participation in this clinical experiment open?

"This medical trial is seeking around 240 participants who have a history of drug abuse and are within the 18 to 65 age range."

Answered by AI

Who else is applying?

What site did they apply to?
NYU Langone Health
What portion of applicants met pre-screening criteria?
Met criteria
~6 spots leftby Jun 2024